Rotate your device

Please rotate your device to landscape mode
for the best experience.

AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Herti 440mg Injection

Prescription Icon
Prescription Required

Marketer

Hetero Healthcare Limited

Salt Composition

Trastuzumab (440mg)

Overview Herti 440mg Injection

Trastuzumab 440mg injection is indicated for breast and gastric cancers. Its mechanism involves targeting and eliminating cancerous cells by suppressing HER2 protein activity. Administration is strictly via injection by a qualified healthcare provider. Dosage and frequency are determined individually by your physician, based on your condition and may vary. Adhere precisely to your doctor's instructions; incorrect usage or overdose may lead to severe adverse reactions. Therapeutic benefits may take weeks or months to manifest; discontinue only under medical guidance. Common side effects include nausea, headache, skin rash, sleep disturbances, and infections. This medication can reduce blood cell counts (both red and white), increasing infection risk. Regular blood tests are essential to monitor blood cell levels, alongside cardiac, hepatic, and uric acid parameters. Report immediately any shortness of breath, cough, chills, or limb swelling. Inform your healthcare team of all other medications you are taking, as interactions are possible. This medication is contraindicated during pregnancy and breastfeeding; reliable contraception for both partners is crucial throughout treatment.

Uses of Herti 440mg Injection

Cancers affecting the breast and stomach.

Major Benefits of Herti 440mg Injection:

This medication will be administered by your healthcare provider; self-medication is strongly discouraged.

Common Side effects of Herti 440mg Injection:

  • Anemia (low number of red blood cells)
  • Chills
  • Common cold
  • Cough
  • Decreased blood cells (red cells, white cells, and platelets)
  • Diarrhea
  • Fatigue
  • Fever
  • Headache
  • Heart failure
  • Infection
  • Insomnia (difficulty in sleeping)
  • Mucosal inflammation
  • Nausea
  • Rash
  • Stomatitis (Inflammation of the mouth)
  • Taste change
  • Upper respiratory tract infection
  • Weight loss

How to use Herti 440mg Injection:

This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.

How Herti 440mg Injection works:

Herti 440mg Injection, a recombinant IgG1 monoclonal antibody, targets HER2 (human epidermal growth factor receptor 2) receptors. By binding to these receptors, it prevents the uncontrolled growth of breast and gastric cancer cells. This action effectively eliminates cancer cells and disrupts multiple downstream signaling pathways crucial for cancer development.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent use of Herti 440mg Injection and alcohol can lead to increased sleepiness.

PregnancyPregnancyCONSULT YOUR DOCTOR

Administering Herti 440mg Injection during pregnancy poses a confirmed risk to the fetus. Its use is contraindicated except in exceptional, life-threatening circumstances where potential benefits outweigh the known hazards, as determined by a physician. Seek medical advice before use.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Administration of Herti 440mg Injection while breastfeeding is likely inadvisable. Available human data indicate potential transfer to breast milk, posing a possible risk to the infant.

DrivingDrivingCONSULT YOUR DOCTOR

The effect of Herti 440mg Injection on driving ability is undetermined. Refrain from driving if you exhibit symptoms impairing concentration or reaction time.

KidneyKidneySAFE IF PRESCRIBED

The use of Herti 440mg Injection in individuals with impaired kidney function appears to pose minimal risk. Preliminary findings indicate dose modification may be unnecessary; however, medical advice is recommended.

LiverLiverCONSULT YOUR DOCTOR

Data regarding Herti 440mg Injection's use in individuals with hepatic impairment is scarce. Physician consultation is advised.

What if you forget to take Herti 440mg Injection :

Should you forget a Herti 440mg Injection, seek your physician's advice.

Facts to Know About Herti 440mg Injection

LabelValue
Chemical Classification Monoclonal antibody
Developing Habits No.
Treatment Category Cancer Therapeutics
Actions Monoclonal Antibody HER2/neu (ErbB2) Inhibitor

FAQs on Herti 440mg Injection

Herti 440mg Injection may cause side effects including sore throat, fever, chills, fatigue, pale skin, nosebleeds, and unusual bleeding or bruising. Other possible side effects are stomach pain, seizures, hallucinations, muscle cramps and spasms, nausea or vomiting, appetite loss, rapid heartbeat, discolored or decreased urine output, painful urination, and other signs of infection. Contact your doctor immediately if you experience any of these symptoms.
Effective contraception should be used by women of childbearing age throughout Herti 440mg Injection therapy and for seven months afterward. Pregnancy planning may resume seven months post-treatment.
Herceptin 440mg Injection should be administered to patients with early-stage breast cancer for one year, or until disease recurrence, whichever comes first. Treatment should not exceed one year.
Herceptin 440mg Injection does not require fasting beforehand. Administration must be by a healthcare professional, under the supervision of a doctor experienced in cancer chemotherapy.
Herti 440mg Injection is available in two formulations: intravenous (IV) infusion and subcutaneous injection. Always verify the correct formulation is administered as prescribed, as the IV formulation is exclusively for intravenous use. Your doctor may change your treatment between IV and subcutaneous Herti 440mg Injection if clinically indicated.
Herti 440mg Injection, a monoclonal antibody, targets the HER2 protein found on some cancer cells. It inhibits cancer growth by binding to HER2. Consequently, this injection is only effective in patients with HER2-positive cancer and is not indicated for those with HER2-negative cancer.
Using Herti 440mg Injection with anthracyclines (like doxorubicin) can harm your heart. Therefore, your doctor must assess your heart health before and throughout treatment.
Cardiac evaluations are required at treatment initiation, every three months during treatment, and every six months post-treatment for up to 24 months after the final Herti 440mg Injection. Patients with pre-existing cardiac conditions need evaluations every 12 weeks.
Herti 440mg Injection
41,713
MRP 48,400
13% off